Hugo ten Cate

Author PubWeight™ 83.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011 2.54
2 Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med 2011 2.28
3 Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008 1.59
4 Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med 2005 1.58
5 Endothelial activation in lacunar stroke subtypes. Stroke 2010 1.55
6 Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med 2007 1.54
7 Infection and inflammation and the coagulation system. Cardiovasc Res 2003 1.49
8 Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable. J Rheumatol 2013 1.49
9 Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 2004 1.35
10 Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006 1.20
11 Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res 2009 1.20
12 Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler Thromb Vasc Biol 2009 1.15
13 Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010 1.14
14 Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis 2005 1.14
15 Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med 2010 1.11
16 Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner. PLoS One 2013 1.11
17 The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS 2009 1.11
18 Endothelium: interface between coagulation and inflammation. Crit Care Med 2002 1.06
19 Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007 1.05
20 Infections and endothelial cells. Cardiovasc Res 2003 1.05
21 Disseminated intravascular coagulation. Hematol J 2003 1.05
22 Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 2009 1.03
23 Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol 2007 1.02
24 Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost 2008 1.02
25 The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded. Thromb Haemost 2011 1.01
26 Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011 1.00
27 The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost 2010 1.00
28 Effects of ambient air pollution on hemostasis and inflammation. Environ Health Perspect 2009 0.99
29 PTX3 predicts severe disease in febrile patients at the emergency department. J Infect 2009 0.96
30 Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One 2012 0.96
31 Absence of platelet-dependent fibrin formation in a patient with Scott syndrome. Thromb Haemost 2009 0.94
32 Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis. JACC Cardiovasc Imaging 2012 0.94
33 The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis 2007 0.94
34 Thrombin generation and atherosclerosis. J Thromb Thrombolysis 2014 0.93
35 Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant 2011 0.93
36 Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion 2008 0.92
37 The blood coagulation system as a molecular machine. Bioessays 2003 0.92
38 Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation. J Am Coll Cardiol 2015 0.92
39 Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost 2008 0.90
40 The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev 2013 0.89
41 Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arterioscler Thromb Vasc Biol 2010 0.89
42 Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography. Haematologica 2012 0.89
43 Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients. Diabetes Res Clin Pract 2010 0.88
44 Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes. Thromb J 2005 0.88
45 Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thromb Haemost 2011 0.87
46 Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction. Thromb J 2006 0.86
47 New insights into modulation of thrombin formation. Curr Atheroscler Rep 2013 0.86
48 Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res 2005 0.86
49 Plasma viscosity and mean platelet volume in patients undergoing coronary angiography. Clin Hemorheol Microcirc 2010 0.86
50 The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems. Hypertension 2005 0.86
51 A pilot study into measurements of markers of atherosclerosis in periodontitis. J Periodontol 2005 0.85
52 Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis. Basic Res Cardiol 2003 0.85
53 Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling. J Clin Invest 2008 0.85
54 The endothelium in intensive care. Crit Care Clin 2005 0.85
55 More fibrosis and thrombotic complications but similar expression patterns of markers for coagulation and inflammation in symptomatic plaques from DM2 patients. J Histochem Cytochem 2004 0.84
56 The structure-function relationship of activated protein C. Lessons from natural and engineered mutations. Thromb Haemost 2011 0.84
57 Signal transduction induced by activated protein C: no role in protection against sepsis? Trends Mol Med 2006 0.84
58 Cardiovascular risk in patients with hemophilia. Blood 2014 0.83
59 Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost 2006 0.82
60 Coagulation on endothelial cells: the underexposed part of Virchow's Triad. Thromb Haemost 2012 0.82
61 ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera. Thromb Res 2013 0.82
62 Thrombin generation in the Glasgow Myocardial Infarction Study. PLoS One 2013 0.82
63 N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann Hematol 2012 0.82
64 Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice. Comp Med 2003 0.81
65 Lung inflammation and thrombogenic responses in a time course study of Csb mice exposed to ozone. J Appl Toxicol 2008 0.81
66 D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review. Thromb Haemost 2013 0.81
67 Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article. J Cardiothorac Surg 2013 0.80
68 A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease. Thromb Haemost 2013 0.80
69 The technique of measuring thrombin generation with fluorogenic substrates: 1. Necessity of adequate calibration. Thromb Haemost 2008 0.80
70 Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J Hypertens 2009 0.79
71 Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation--the Hoorn Study. Thromb Res 2011 0.79
72 The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up. Thromb Haemost 2011 0.79
73 Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model. Thromb Haemost 2015 0.78
74 Activation of the contact system in patients with a first acute myocardial infarction. Thromb Res 2013 0.78
75 Anticoagulant therapy in critical organ ischaemia/reperfusion injury. Thromb Haemost 2010 0.77
76 Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost 2015 0.77
77 Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers. Thromb Haemost 2014 0.77
78 Reply to Faraoni D, Fenger-Eriksen C, Gillard S et al. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study. Paediatr Anaesth 2015 0.77
79 Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding. PLoS One 2013 0.76
80 Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagul Fibrinolysis 2007 0.76
81 High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation. Clin Chem Lab Med 2005 0.76
82 The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test. Thromb Res 2012 0.76
83 Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 2003 0.76
84 Effects of ultrapure hemodialysis and low molecular weight heparin on the endothelial surface layer. Blood Purif 2014 0.76
85 Rivaroxaban for thromboprophylaxis. N Engl J Med 2008 0.75
86 Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Lancet 2003 0.75
87 Dabigatran and apolipoprotein B. Heart 2015 0.75
88 Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis 2002 0.75
89 Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review. Thromb Haemost 2015 0.75
90 [Better understanding of blood coagulation in vivo]. Ned Tijdschr Geneeskd 2009 0.75
91 Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients. Biomark Med 2014 0.75
92 Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis. Curr Pharm Des 2013 0.75
93 Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004 0.75
94 [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events]. Ned Tijdschr Geneeskd 2009 0.75
95 Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome. Ann N Y Acad Sci 2009 0.75
96 Long-term strenuous exercise induces a hypercoagulable state through contact activation. Thromb Haemost 2014 0.75